IPR2020-01252 - Pfizer Inc v. Novo Nordisk AS et al.Report Error
Details
PATENT NUMBER
APPL. NUMBER
11435977
STATUS
FILING DATE
2020-07-22
INSTITUTION DATE
2020-12-04
TERMINATION DATE
N/A
AUTHOR JUDGE
Timeline
Petition
Motion for Joinder
Notice of Filing Date
Institution Decision
Final Decision
Jul
Aug
Sep
Oct
Nov
Dec
2021
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
2022
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
Docket
| 1 | 2020-07-22 | Petitioner | Power of Attorney | Petitioner's Power of Attorney |
| 2 | 2020-07-22 | Petitioner | Petition | IPR Petition '833 |
| 3 | 2020-07-22 | Petitioner | Motion for Joinder | MOTION FOR JOINDER |
| 1001 | 2020-07-22 | Petitioner | Ex. 1001 - U.S. Patent No. 8,114,833 | |
| 1002 | 2020-07-22 | Petitioner | Ex. 1002 - EXPERT DECLARATION OF LAIRD FORREST, Ph.D. | |
| 1003 | 2020-07-22 | Petitioner | Ex. 1003 - Prosecution history excerpts for U.S. Patent No. 8,114,833 | |
| 1004 | 2020-07-22 | Petitioner | Ex. 1004 - International Publication NO. WO 03/002136. | |
| 1005 | 2020-07-22 | Petitioner | Ex. 1005 - International Publication No. WO 2004/004781 | |
| 1006 | 2020-07-22 | Petitioner | Ex. 1006 - U.S. Patent No. 6,268,343 | |
| 1007 | 2020-07-22 | Petitioner | Ex. 1007 - EP 0 923 950 | |
| 1008 | 2020-07-22 | Petitioner | Ex. 1008- Powell et al., Parenteral Peptide Formulations | |
| 1009 | 2020-07-22 | Petitioner | Ex. 1009 - E. Epperson, Mannitol Crystallization in Plastic Containers | |
| 1010 | 2020-07-22 | Petitioner | Ex. 1010 - Griffin et al., Polyhydric Alcohols | |
| 1011 | 2020-07-22 | Petitioner | Ex. 1011 - J. Jacobs, Factors Influencing Drug | |
| 1012 | 2020-07-22 | Petitioner | Ex. 1012 - MODERN PHARMACEUTICS -Part 1 | |
| 1013 | 2020-07-22 | Petitioner | Ex. 1013 - REMINGTON'S PHARMACEUTICAL SCIENCES (18th ed. 1990) Part 1 | |
| 1014 | 2020-07-22 | Petitioner | Ex. 1014 -International Publication No. WO 03/072195 | |
| 1017 | 2020-07-22 | Petitioner | Ex. 1017- U.S. Patent No. 8,759,291 | |
| 1018 | 2020-07-22 | Petitioner | Ex. 1018 - U.S. Patent Application Publication US 2005/0 48497 | |
| 1019 | 2020-07-22 | Petitioner | Ex. 1019 - International Publication No. WO 95/22560 A1 | |
| 1020 | 2020-07-22 | Petitioner | Ex. 1020 - U.S. Patent No. 6,458,924 | |
| 1021 | 2020-07-22 | Petitioner | Ex. 1021 - International Publication No. WO 00/37098 A1 | |
| 1022 | 2020-07-22 | Petitioner | Ex. 1022 - Handbook of Pharmaceutical Excipients (3d ed. 2000) | |
| 1023 | 2020-07-22 | Petitioner | Ex. 1023 - Handbook of Pharmaceutical Excipients (3d ed. 2000) Part 2 | |
| 1024 | 2020-07-22 | Petitioner | Ex. 1024 -Akers, Formulation Development of Protein Dosage Forms - Part 1 | |
| 1025 | 2020-07-22 | Petitioner | Ex. 1025 - International Patent Publication No. WO 1999/040788 | |
| 1026 | 2020-07-22 | Petitioner | Ex, 1026 - DEVELOPMENT OF BIOPHARMACEUTICAL PARENTERAL DOSAGE FORMS (John A. Bontempo ed., 1997) | |
| 1027 | 2020-07-22 | Petitioner | Ex. 1027 -Gaitlin, Formulation and Administration Techniques | |
| 1028 | 2020-07-22 | Petitioner | Ex. 1028 - A DICTIONARY OF CHEMISTRY (1996) (excerpts) | |
| 1029 | 2020-07-22 | Petitioner | Ex. 1029 - FDA Guidance for Industry - Chemistry Manufacturing and Controls (2003) | |
| 1030 | 2020-07-22 | Petitioner | Ex. 1030 - U.S. Patent No. 5,514,097 | |
| 1031 | 2020-07-22 | Petitioner | Ex. 1031 - International Publication No. WO 93/19175 | |
| 1032 | 2020-07-22 | Petitioner | Ex. 1032 - International Publication No. WO 99/43705 | |
| 1033 | 2020-07-22 | Petitioner | Ex. 1033 - International Publication No. WO 99/43706 Part 3 | |
| 1034 | 2020-07-22 | Petitioner | Ex. 1034 - International Publication No. WO 99/43707 | |
| 1035 | 2020-07-22 | Petitioner | Ex. 1035 - International Publication No. WO 98/08871 | |
| 1036 | 2020-07-22 | Petitioner | Ex. 1036 - International Publication No. WO 99/43341 | |
| 1037 | 2020-07-22 | Petitioner | Ex. 1037 - International Publication No. WO 99/43708 | |
| 1038 | 2020-07-22 | Petitioner | Ex. 1038 - International Publication No. WO 99/43341 | |
| 1039 | 2020-07-22 | Petitioner | Ex. 1039 - International Publication No. WO 87/06941 | |
| 1040 | 2020-07-22 | Petitioner | Ex. 1040 -International Publication No. WO 0/11296 | |
| 1041 | 2020-07-22 | Petitioner | Ex. 1041 - International Publication No. WO 91/11457 | |
| 1042 | 2020-07-22 | Petitioner | Ex, 1042 - International Publication No. WO 98/43658 | |
| 1043 | 2020-07-22 | Petitioner | Ex. 1043 - International Publication No. EP 0 708 179 | |
| 1044 | 2020-07-22 | Petitioner | Ex. 1044 - International Publication No. EP 0 699 686 | |
| 1045 | 2020-07-22 | Petitioner | Ex. 1045 - International Publication No. WO 01/98331 | |
| 1046 | 2020-07-22 | Petitioner | Ex. 1046 - J. Sturis et al., GLP-1 Derivative Liraglutide in Rats with ¿¿-cell Deficiencies | |
| 1047 | 2020-07-22 | Petitioner | Ex. 1047 - Fransson et al., Local Tolerance of Subcutaneous Injections | |
| 1048 | 2020-07-22 | Petitioner | Ex. 1048 - L. Gerweck et al., Cellular pH Gradient in Tumor Versus Normal Tissue: Potential Exploitation for the Treatment of Cancer | |
| 1049 | 2020-07-22 | Petitioner | Ex. 1049 - Madshus, Regulation of Intracellular pH in Eukaryotic Cells | |
| 1050 | 2020-07-22 | Petitioner | Ex. 1050 - C. Fox et al., Ability to Handle, and Patient Preference for, Insulin Delivery Devices in Visually Impaired Patients with Type 2 Diabetes | |
| 1051 | 2020-07-22 | Petitioner | Ex. 1051 - A.M. Robinson et al., Subcutaneous Versus Intravenous Administration of Heparin in the Treatment of Deep Vein Thrombosis | |
| 1052 | 2020-07-22 | Petitioner | Ex. 1052 - D. Schade et al., The Intravenous, Intraperitoneal, and Subcutaneous Routes of Insulin Delivery in Diabetic | |
| 1053 | 2020-07-22 | Petitioner | Ex. 1053 - X.H. Zhou et al., Peptide and Protein Drugs | |
| 1054 | 2020-07-22 | Petitioner | .Ex. 1054 - Napaporn et al., Assessment of the Myotoxicity of Pharmaceutical Buffers Using an In vitro Muscle Model | |
| 1055 | 2020-07-22 | Petitioner | Ex. 1055 - C.M.B. Edwards et al., Peptides as Drugs | |
| 1056 | 2020-07-22 | Petitioner | Ex. 1056 - C. Akiyama et al., Comparison of Behavior in Muscle Fiber Regeneration After Bupivacaine Hydrochloride- and Acid Anhydride-Induced Myonecrosis | |
| 1057 | 2020-07-22 | Petitioner | Ex. 1057 - Alfred Martin, PHYSICAL PHARMACY (4th ed. 1993) | |
| 1058 | 2020-07-22 | Petitioner | Ex. 1058 - S. Borchert et al., Particulate Matter in Parenteral Products | |
| 1059 | 2020-07-22 | Petitioner | Ex. 1059 - X. Chang et al., NMR Studies of the Aggregation of Glucagon-Like Peptide-1: Formation of a Symmetric Helical Dimer | |
| 1060 | 2020-07-22 | Petitioner | Ex. 1060 - M. Stranz et al., A Review of pH and Osmolarity | |
| 1061 | 2020-07-22 | Petitioner | Ex. 1061 - PHARMACEUTICS THE SCIENCE OF DOSAGE FORM DESIGN | |
| 1062 | 2020-07-22 | Petitioner | Ex. 1062 - D. Dubost et al., Characterization of a Solid State Reaction Product from a Lyophilized Formulation of a Cyclic Heptapeptide. A Novel Example of an Excipient-Induced Oxidation | |
| 1063 | 2020-07-22 | Petitioner | Ex. 1063 - U.S. Patent No. 4,425,346 | |
| 1064 | 2020-07-22 | Petitioner | Ex. 1064 - U.S. Patent No. 6,207,684 | |
| 1065 | 2020-07-22 | Petitioner | Ex. 1065 - U.S. Patent No. 6,440,460 | |
| 1066 | 2020-07-22 | Petitioner | .Ex. 1066 -Bothe et al., Peptide Oligomerization Memory Effects and Their Impact on the Physical Stability of the LP-1 Agonist Liraglutide | |
| 1067 | 2020-07-22 | Petitioner | Ex. 1067 - M.J. Akers, Excipient-Drug Interactions in Parenteral Formulations, | |
| 1068 | 2020-07-22 | Petitioner | Ex. 1068 - U.S. PHARMACOPEIA XXII, NATIONAL FORMULARY XVII (1990) -Part 1 | |
| 1069 | 2020-07-22 | Petitioner | Ex. 1069 - R. Noel, Statistical Quality Control in the Manufacture of Pharmaceuticals | |
| 1070 | 2020-07-22 | Petitioner | Ex. 1070 - NOTE FOR GUIDANCE SPECIFICATIONS: | |
| 1071 | 2020-07-22 | Petitioner | Ex. 1071 - M. Gnanalingham et al., Accuracy and Reproducibility of Low Dose Insulin Administration Using Pen-Injectors and Syringes | |
| 1072 | 2020-07-22 | Petitioner | Ex. 1072 - C. Burke et al., The Adsorption of Proteins to Pharmaceutical Container Surfaces | |
| 1073 | 2020-07-22 | Petitioner | Ex. 1073 - T. Asakura et al., Occurrence of Coring in Insulin Vials and Possibility of Rubber Piece Contamination by Self-Injection | |
| 1074 | 2020-07-22 | Petitioner | Ex. 1074 - M. Roe et al., Dose Accuracy Testing of the Humalog | |
| 1075 | 2020-07-22 | Petitioner | Ex. 1075 - Parenteral Drug Association, Points to Consider for Cleaning Validation. Technical Report No. 29 - Part 2 | |
| 1076 | 2020-07-22 | Petitioner | Ex. 1076 -WIPO Patentscope PCT Bibliography Data for PCTDK2004000792 | |
| 4 | 2020-08-12 | Potential Patent Owner | Mandatory Notice | Patent Owner's Mandatory Notice |
| 5 | 2020-08-12 | Potential Patent Owner | Power of Attorney | Patent Owner's Power of Attorney |
| 6 | 2020-08-21 | Board | Notice of Filing Date | Notice of Accord Filing Date |
| 7 | 2020-12-04 | Board | Institution Decision | Trial Instituted Document |
| 8 | 2021-06-24 | Board | Other | DECISION Granting Patent Owner's Unopposed Renewed Motion to Seal Exhibits 2023, 1078, and 1079 |
| 9 | 2021-07-01 | Board | Final Decision | ORDER Granting Joint Motion to Terminate the Proceeding and Joint Request to Treat Settlement Documents as Business Confidential Information (Paper 80 from joined IPR2020-00324) |
Grounds Asserted